| Warkim R Giles, CRNA | |
|
200 S 5th St Ste A, Salina, KS 67401-3906 | |
| (785) 827-2238 | |
| (785) 827-1684 |
| Full Name | Warkim R Giles |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 200 S 5th St Ste A, Salina, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497236053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 557658 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Topeka Pa | 5698675437 | 54 |
News Archive
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
ZYTO Corp reported record financial results for the full fiscal year ended December 31, 2009, including its highest-ever annual revenues, operating income and earnings per share.
In response to the issues raised by the Jan. 24 New York Times article, "Radiation Offers New Cures and Ways to Do Harm," US Oncology, Inc. wants to ensure that cancer patients and the general public understand that the benefits received from radiation therapy in cancer care far outweigh the risks, and that cancer patients fighting their disease with help from the US Oncology physician network, and their loved ones, can rest assured that extensive quality control measures are put in place to minimize risks.
› Verified 6 days ago
| Entity Name | Anesthesia Associates Of Topeka Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518933837 PECOS PAC ID: 5698675437 Enrollment ID: O20040109000467 |
News Archive
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
ZYTO Corp reported record financial results for the full fiscal year ended December 31, 2009, including its highest-ever annual revenues, operating income and earnings per share.
In response to the issues raised by the Jan. 24 New York Times article, "Radiation Offers New Cures and Ways to Do Harm," US Oncology, Inc. wants to ensure that cancer patients and the general public understand that the benefits received from radiation therapy in cancer care far outweigh the risks, and that cancer patients fighting their disease with help from the US Oncology physician network, and their loved ones, can rest assured that extensive quality control measures are put in place to minimize risks.
› Verified 6 days ago
| Entity Name | Anesthesia Associates Of Central Kansas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164494084 PECOS PAC ID: 6406744093 Enrollment ID: O20040121000483 |
News Archive
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
ZYTO Corp reported record financial results for the full fiscal year ended December 31, 2009, including its highest-ever annual revenues, operating income and earnings per share.
In response to the issues raised by the Jan. 24 New York Times article, "Radiation Offers New Cures and Ways to Do Harm," US Oncology, Inc. wants to ensure that cancer patients and the general public understand that the benefits received from radiation therapy in cancer care far outweigh the risks, and that cancer patients fighting their disease with help from the US Oncology physician network, and their loved ones, can rest assured that extensive quality control measures are put in place to minimize risks.
› Verified 6 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
ZYTO Corp reported record financial results for the full fiscal year ended December 31, 2009, including its highest-ever annual revenues, operating income and earnings per share.
In response to the issues raised by the Jan. 24 New York Times article, "Radiation Offers New Cures and Ways to Do Harm," US Oncology, Inc. wants to ensure that cancer patients and the general public understand that the benefits received from radiation therapy in cancer care far outweigh the risks, and that cancer patients fighting their disease with help from the US Oncology physician network, and their loved ones, can rest assured that extensive quality control measures are put in place to minimize risks.
› Verified 6 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20050302000266 |
News Archive
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
ZYTO Corp reported record financial results for the full fiscal year ended December 31, 2009, including its highest-ever annual revenues, operating income and earnings per share.
In response to the issues raised by the Jan. 24 New York Times article, "Radiation Offers New Cures and Ways to Do Harm," US Oncology, Inc. wants to ensure that cancer patients and the general public understand that the benefits received from radiation therapy in cancer care far outweigh the risks, and that cancer patients fighting their disease with help from the US Oncology physician network, and their loved ones, can rest assured that extensive quality control measures are put in place to minimize risks.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Warkim R Giles, CRNA Po Box 1607, Salina, KS 67402-1607 Ph: (785) 827-2238 | Warkim R Giles, CRNA 200 S 5th St Ste A, Salina, KS 67401-3906 Ph: (785) 827-2238 |
News Archive
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
ZYTO Corp reported record financial results for the full fiscal year ended December 31, 2009, including its highest-ever annual revenues, operating income and earnings per share.
In response to the issues raised by the Jan. 24 New York Times article, "Radiation Offers New Cures and Ways to Do Harm," US Oncology, Inc. wants to ensure that cancer patients and the general public understand that the benefits received from radiation therapy in cancer care far outweigh the risks, and that cancer patients fighting their disease with help from the US Oncology physician network, and their loved ones, can rest assured that extensive quality control measures are put in place to minimize risks.
› Verified 6 days ago
Christina Thongphanh, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Mrs. Melinda Trogstad, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Mr. Hugh J Hyberger, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 520 S Santa Fe Ave, Suite 260, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Anne Njoki Njoroge, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Shannon Mawyin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 520 S Santa Fe Ave, 260, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Andrew Edward Pecore, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 | |
Mr. Christopher John Schroeder, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S 5th St Ste A, Salina, KS 67401 Phone: 785-827-2238 Fax: 785-827-1684 |